Arthritis Today - October 2004

Issue 126

Arthritis Today Issue 126 CoverAnti-TNF – a gradual miracle

Thirty-nine year old Andrew Ford was in remission from juvenile idiopathic arthritis for many years before it returned with a vengeance. He became one of the first patients to receive anti-TNF therapy. He tells his story to Arthritis Today.

Focus on Cambridge

Addenbrookes Hospital in Cambridge is awash with new advances in science, research, and technology, but arthritis research is holding its own. Jane Tadman reports.

Helping people with arthritis to help themselves

What can the Expert Patients Programme offer people with arthritis? Jane Tadman reports.

Joint approach to common condition

As arc's commitment to funding work into osteoarthritis reaches nearly £6million, new avenues of research offer real hope for the future, suggests Jerry Saklatvala.

Hormones, pregnancy and inflammatory arthritis

Hormones play a major if largely misunderstood role in various kinds of inflammatory arthritis, explains Caroline Gordon.

Yesterday, Today and Tomorrow; 50 years of epidemiology

Mary Ingram looks back on how the Arthritis Research Campaign's Epidemiology Unit has changed over the past half century.

Spotlight on science

Dr Michael Ehrenstein and Dr Sarah Hewlett explain their work in an ongoing series of questions and answers with arc-funded researchers.